In Mendelian randomisation analyses, interleukin-6 inhibition was predicted to have a large protective effect on the incidence of infection (OR 0.23; 95% CI 0.14–0.39 per standard deviation decrease in C- reactive protein). This evidence concerns the gene CRP and infection.